BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 22285514)

  • 1. Chimeric classical swine fever (CSF)-Japanese encephalitis (JE) viral replicon as a non-transmissible vaccine candidate against CSF and JE infections.
    Yang Z; Wu R; Li RW; Li L; Xiong Z; Zhao H; Guo D; Pan Z
    Virus Res; 2012 Apr; 165(1):61-70. PubMed ID: 22285514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV.
    Maurer R; Stettler P; Ruggli N; Hofmann MA; Tratschin JD
    Vaccine; 2005 May; 23(25):3318-28. PubMed ID: 15837238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classical swine fever virus replicon particles lacking the Erns gene: a potential marker vaccine for intradermal application.
    Frey CF; Bauhofer O; Ruggli N; Summerfield A; Hofmann MA; Tratschin JD
    Vet Res; 2006; 37(5):655-70. PubMed ID: 16777037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the cell-mediated immunity induced by alphavirus replicon-vectored DNA vaccines against classical swine fever in a mouse model.
    Zhao HP; Sun JF; Li N; Sun Y; Xia ZH; Wang Y; Cheng D; Qi QF; Jin ML; Qiu HJ
    Vet Immunol Immunopathol; 2009 May; 129(1-2):57-65. PubMed ID: 19150136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic and replicative properties of classical swine fever virus replicon particles modified to induce IFN-α/β and carry foreign genes.
    Suter R; Summerfield A; Thomann-Harwood LJ; McCullough KC; Tratschin JD; Ruggli N
    Vaccine; 2011 Feb; 29(7):1491-503. PubMed ID: 21184857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever.
    Sun Y; Li HY; Tian DY; Han QY; Zhang X; Li N; Qiu HJ
    Vaccine; 2011 Oct; 29(46):8364-72. PubMed ID: 21888938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of pigs from lethal challenge by a DNA vaccine based on an alphavirus replicon expressing the E2 glycoprotein of classical swine fever virus.
    Li N; Zhao JJ; Zhao HP; Sun Y; Zhu QH; Tong GZ; Qiu HJ
    J Virol Methods; 2007 Sep; 144(1-2):73-8. PubMed ID: 17499369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus.
    Reimann I; Depner K; Trapp S; Beer M
    Virology; 2004 Apr; 322(1):143-57. PubMed ID: 15063124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
    Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
    Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
    Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F
    Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Semliki Forest virus replicon vectored DNA vaccine expressing the E2 glycoprotein of classical swine fever virus protects pigs from lethal challenge.
    Li N; Qiu HJ; Zhao JJ; Li Y; Wang MJ; Lu BW; Han CG; Hou Q; Wang ZH; Gao H; Peng WP; Li GX; Zhu QH; Tong GZ
    Vaccine; 2007 Apr; 25(15):2907-12. PubMed ID: 17007970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies.
    Aebischer A; Müller M; Hofmann MA
    Vet Microbiol; 2013 Jan; 161(3-4):274-85. PubMed ID: 22902189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV.
    van Gennip HG; Bouma A; van Rijn PA; Widjojoatmodjo MN; Moormann RJ
    Vaccine; 2002 Feb; 20(11-12):1544-56. PubMed ID: 11858861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response.
    Lin GJ; Liu TY; Tseng YY; Chen ZW; You CC; Hsuan SL; Chien MS; Huang C
    Vet Microbiol; 2009 Nov; 139(3-4):369-74. PubMed ID: 19625145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
    Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA
    Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines.
    Wehrle F; Renzullo S; Faust A; Beer M; Kaden V; Hofmann MA
    J Gen Virol; 2007 Aug; 88(Pt 8):2247-2258. PubMed ID: 17622629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats.
    Barrera M; Sánchez O; Farnós O; Rodríguez MP; Domínguez P; Tait H; Frías M; Avila M; Vega E; Toledo JR
    Vet Immunol Immunopathol; 2010 Jan; 133(1):25-32. PubMed ID: 19640591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a new chimeric marker vaccine candidate with a mutated antigenic E2-epitope.
    Reimann I; Depner K; Utke K; Leifer I; Lange E; Beer M
    Vet Microbiol; 2010 Apr; 142(1-2):45-50. PubMed ID: 19892497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive evaluation of the adenovirus/alphavirus-replicon chimeric vector-based vaccine rAdV-SFV-E2 against classical swine fever.
    Sun Y; Tian DY; Li S; Meng QL; Zhao BB; Li Y; Li D; Ling LJ; Liao YJ; Qiu HJ
    Vaccine; 2013 Jan; 31(3):538-44. PubMed ID: 23153441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.